Skip to main content

Table 1 Demographic features

From: Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial

Variable

α-galactosidase

placebo

P

(N = 27)

(N = 25)

Demographic data

   

Gender: n (%)

   

  male

11

(41%)

9

(36%)

0.73

  female

16

(59%)

16

(64%)

Age (yrs): n (%)

   

  <8

12

(44%)

10

(40%)

0.75

  > = 8

15

(56%)

15

(60%)

Weight (kg): n (%)

   

  ≤20

9

(33%)

7

(28%)

0.92

  >20, ≤40

7

(26%)

7

(28%)

  >40

11

(41%)

11

(44%)